NasdaqCM - Delayed Quote • USD
Bio-Path Holdings, Inc. (BPTH)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:44 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Operating Income
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Net Non Operating Interest Income Expense
36.0000
36.0000
33.0000
3.0000
26.0000
Other Income Expense
-271.0000
-271.0000
--
--
--
Pretax Income
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Net Income Common Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Diluted NI Available to Com Stockholders
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Basic EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Diluted EPS
-40.00
-33.63
-38.12
-31.00
-56.60
Basic Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Diluted Average Shares
420.2380
478.0000
364.0000
336.2500
192.3500
Total Operating Income as Reported
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
Total Expenses
15,843.0000
15,843.0000
13,901.0000
10,443.0000
10,908.0000
Net Income from Continuing & Discontinued Operation
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Normalized Income
-15,807.0000
-15,807.0000
-13,868.0000
-10,440.0000
-10,882.0000
Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
Net Interest Income
36.0000
36.0000
33.0000
3.0000
26.0000
EBIT
-15,843.0000
-15,843.0000
-13,901.0000
-10,443.0000
-10,908.0000
EBITDA
-15,665.0000
-15,665.0000
-13,723.0000
-10,282.0000
-10,757.0000
Reconciled Depreciation
178.0000
178.0000
178.0000
161.0000
151.0000
Net Income from Continuing Operation Net Minority Interest
-16,078.0000
-16,078.0000
-13,868.0000
-10,440.0000
-10,882.0000
Total Unusual Items Excluding Goodwill
-271.0000
-271.0000
--
--
--
Total Unusual Items
-271.0000
-271.0000
--
--
--
Normalized EBITDA
-15,394.0000
-15,394.0000
-13,723.0000
-10,282.0000
-10,757.0000
12/31/2020 - 3/4/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PALI Palisade Bio, Inc.
6.05
-2.89%
TVGN Tevogen Bio Holdings Inc.
1.0000
+17.65%
PCSA Processa Pharmaceuticals, Inc.
2.1500
-11.52%
NKGN NKGen Biotech, Inc.
1.6100
-18.69%
MLEC Moolec Science SA
1.4500
+2.11%
BDRX Biodexa Pharmaceuticals Plc
1.3000
+80.56%
LGVN Longeveron Inc.
1.7500
+4.79%
CADL Candel Therapeutics, Inc.
6.39
-0.62%
ADIL Adial Pharmaceuticals, Inc.
1.6100
-6.94%
ALLR Allarity Therapeutics, Inc.
1.4600
+2.10%